About 200 reports

You can easily book an appointment with one online.

  • Chemotherapy
  • Amgen Inc.
  • Intas Pharmaceuticals Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Chemotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Chemotherapy
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • 3.3.2 VECTIBIX (PANITUMUMAB) - AMGEN/TAKEDA

Side effects of targeted therapies are often less frequent and severe, although dermatological issues and diarrhea still pose problems.

  • Chemotherapy
  • Colorectal Cancer
  • Therapy
  • Market Size
  • Merck & Co., Inc.

Clinical, Cosmetic and Investigational Dermatology; ##: ##-## Experimental Elliot S, et al. (2008).

  • Chemotherapy
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Insys Therapeutics, Inc.

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Chemotherapy
  • China
  • Supply
  • Tianjin Tianyao Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.
  • 3.3.1 ERBITUX (CETUXIMAB) - ELI LILLY/MERCK KGAA
  • 3.3 Epidermal Growth Factor Receptor Targeted Therapies

British Journal of Dermatology; ##(##): ##-## Yang CH (2008).

  • Chemotherapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Chemotherapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd

The side effects of targeted therapies are often less frequent and severe, although dermatological issues and diarrhea still pose problems.

  • Cancer
  • Chemotherapy
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • SUMMARIZES THE RESULT OF THE PHASE III TRIAL OF VECTIBIX AS MONOTHERAPY.
  • SUMMARY OF THE RESULTS FROM THE PHASE III STUDY OF VECTIBIX AS MONOTHERAPY

IN GENERAL, DERMATOLOGICAL TOXICITIES ARE THE MOST COMMON AE IN PATIENTS RECEIVING ERBITUX.

  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

Manufactures prescription medicines for the treatment of dermatology, gynecology, diabetes, oncology, and cardiovascular diseases.

  • Chemotherapy
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group

Manufactures prescription medicines for the treatment of dermatology, gynecology, diabetes, oncology, and cardiovascular diseases.

  • Chemotherapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.
  • EFFICACY OF PORTRAZZA IN FIRST-LINE, SQUAMOUS NSCLC

THE MOST COMMON DRUG-RELATED AES WERE MILD-TO-MODERATE IN INTENSITY AND COMPRISED GI AND DERMATOLOGIC DISORDERS. ##. ##. ##. ##. ## Safety Pipeline Assessment TABLE ## PRESENTS THE SAFETY PROFILE OF OLMUTINIB.

  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • 6.4.3 ERBITUX (CETUXIMAB)

IN GENERAL, DERMATOLOGICAL TOXICITIES ARE THE MOST COMMON AE IN PATIENTS RECEIVING ERBITUX.

  • Chemotherapy
  • Japan
  • United States
  • AstraZeneca PLC
  • Merck & Co., Inc.

These syndromes may affect diverse organ systems, most notably the endocrine, neurologic, dermatologic, rheumatologic, and hematologic systems (Pelosof and Gerber, 2010).

  • Chemotherapy
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Johnson & Johnson
  • Pfizer Inc.

(USA) ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

(USA) ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

(Israel) ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

COMPANY SNIPPETS.............. ## ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

(Germany) ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

(USA) ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

(Canada) ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

COMPANY SNIPPETS.............. ## ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

(Canada) ##.

  • Chemotherapy
  • China
  • United States
  • World
  • Market Shares

(USA) ##.

  • Chemotherapy
  • Therapy
  • United States
  • World
  • Market Shares

(USA) ##.

  • Chemotherapy
  • Therapy
  • United States
  • World
  • Market Shares

(USA) ##.

  • Cancer
  • Chemotherapy
  • United States
  • World
  • Market Shares